Download presentation
Presentation is loading. Please wait.
Published byJuan Carlos Ortiz de Zárate Modified over 6 years ago
1
Clinical Significance of Tumor-Infiltrating Lymphocytes in Lung Neoplasms
Enrico Ruffini, MD, Sofia Asioli, MD, Pier Luigi Filosso, MD, Paraskevas Lyberis, MD, Maria Cristina Bruna, MD, Luigia Macrì, MD, Lorenzo Daniele, MD, Alberto Oliaro, MD The Annals of Thoracic Surgery Volume 87, Issue 2, Pages (February 2009) DOI: /j.athoracsur Copyright © 2009 The Society of Thoracic Surgeons Terms and Conditions
2
Fig 1 Survival according to the presence or absence of tumor-infiltrating lymphocytes (TIL) in total population of patients with lung neoplasms who underwent resection (p = 0.20). The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2009 The Society of Thoracic Surgeons Terms and Conditions
3
Fig 2 Survival according to the presence or absence of tumor-infiltrating lymphocytes (TIL) in population of patients for lung squamous cell carcinoma who underwent resection (p = 0.03). The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2009 The Society of Thoracic Surgeons Terms and Conditions
4
Fig 3 Survival according to the presence or absence of tumor-infiltrating lymphocytes (TIL) in population of patients with stage I lung squamous cell carcinoma who underwent resection (p = 0.03). The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2009 The Society of Thoracic Surgeons Terms and Conditions
5
Fig 4 Survival according to the presence or absence of tumor-infiltrating lymphocytes (TIL) in population of patients with stage I lung adenocarcinoma who underwent resection (p = 0.63). The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2009 The Society of Thoracic Surgeons Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.